Breaking News Instant updates and real-time market news.

NKTR

Nektar

$54.14

1.19 (2.25%)

07:07
06/11/18
06/11
07:07
06/11/18
07:07

Nektar downgraded to Neutral from Buy at H.C. Wainwright

H.C. Wainwright analyst Debjit Chattopadhyay downgraded Nektar Therapeutics to Neutral and cut his price target for the shares to $54 from $97. The stock closed Friday up $1.17 to $54.14. An updated cut of NKTR-214 data presented at an investor conference on June 06, does not assuage fears on the outlook of NKTR-214 in the post ECHO-301, immuno-oncology combination therapy landscape, Chattopadhyay tells investors in a research note. This has been "further punctured by the lack of meaningful updates" in non-small-cell lung carcinoma, the primary driver of NKTR-214's valuation in an environment where competition is better positioned, the analyst contends. Chattopadhyay now has a "less than sanguine read of the emerging data" from Nektar.

  • 12

    Jun

NKTR Nektar
$54.14

1.19 (2.25%)

06/04/18
HCWC
06/04/18
NO CHANGE
Target $97
HCWC
Buy
Nektar price target lowered to $97 from $125 at H.C. Wainwright
H.C. Wainwright analyst Debjit Chattopadhyay lowered his price target for Nektar Therapeutics to $97 saying the "ASCO "euphoria was punctured by" by a lack of meaningful updates in non-small cell lung cancer and drop-off in overall resopnse rate in renal cell carcinoma and melanoma. The analyst says his "optimism has been eroded somewhat," but he keeps a Buy rating on shares of Nektar.
06/04/18
JPMS
06/04/18
NO CHANGE
Target $78
JPMS
Neutral
Nektar price target lowered to $78 from $90 at JPMorgan
JPMorgan analyst Jessica Fye lowered her price target for Nektar Therapeutics to $78 while keeping an Overweight rating on the shares. The analyst expects near-term volatility based on "immature response rate data" that she says came in on the low end of Street expectations as well as a lack of an update on the lung patients treated to-date. Fye, however, remains supportive of the long-term potential for NKTR-214.
06/04/18
WBLR
06/04/18
NO CHANGE
WBLR
Outperform
William Blair optimism on NKTR-214 remains unchanged
William Blair analyst Andy Hsieh says his long-term optimism on Nektar Therapeutics' NKTR-214 remains unchanged following this weekend's update. Given the recent epacadostat setback, there has been increasing scrutiny around data generated from single-arm uncontrolled studies from both the medical and investment communities, Hsieh tells investors in a research note. The analyst thinks the new data will not quell the bearish views on NKTR-21 and that investor confusion about the Fleming analysis could further add volatility to today's trading session. He believes the true potential of NKTR-214 might not be fully realized until later this year and keeps an Outperform rating on Nektar.
06/05/18
ADAM
06/05/18
NO CHANGE
Target $94
ADAM
Buy
Nektar data suggests it could play pivotal role in cancer, says Canaccord
Canaccord analyst Arlinda Lee said data for Nektar's NKTR-214+Opdivo continues to show promise and she believes it is indicative of having a central role in cancer therapy with its broad mechanism of expanding and activating T-effector cells and efficacy. She reiterated her Buy rating and $94 price target on Nektar shares, which fell nearly 42% to $52.57 yesterday.

TODAY'S FREE FLY STORIES

NTRS

Northern Trust

$85.86

-1.3 (-1.49%)

06:36
06/18/19
06/18
06:36
06/18/19
06:36
Downgrade
Northern Trust rating change  »

Northern Trust downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

BK

BNY Mellon

$43.95

-0.54 (-1.21%)

06:36
06/18/19
06/18
06:36
06/18/19
06:36
Downgrade
BNY Mellon rating change  »

BNY Mellon downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 06

    Aug

PSN

Parsons

$31.33

-0.39 (-1.23%)

06:36
06/18/19
06/18
06:36
06/18/19
06:36
Earnings
Parsons reports Q1 adj. EPS 57c, consensus 13c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

SCHW

Charles Schwab

$40.60

-0.41 (-1.00%)

06:36
06/18/19
06/18
06:36
06/18/19
06:36
Downgrade
Charles Schwab rating change  »

Charles Schwab downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

ALXN

Alexion

$120.11

2.17 (1.84%)

06:35
06/18/19
06/18
06:35
06/18/19
06:35
Hot Stocks
Alexion announces approval of Ultomiris in Japan »

Alexion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

GCP

GCP Applied Technologies

$26.36

-0.3 (-1.13%)

06:34
06/18/19
06/18
06:34
06/18/19
06:34
Hot Stocks
GCP Applied Technologies to pursue standalone strategic plan »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRZ

New Residential

$15.58

0.12 (0.78%)

06:33
06/18/19
06/18
06:33
06/18/19
06:33
Hot Stocks
New Residential enters into APA to acquire forward assets of Ditech Financial »

New Residential…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$83.30

0.52 (0.63%)

, AZN

AstraZeneca

$39.98

0.3 (0.76%)

06:32
06/18/19
06/18
06:32
06/18/19
06:32
Hot Stocks
Merck, AstraZeneca announce LYNPARZA approved in EU »

AstraZeneca (AZN) and…

MRK

Merck

$83.30

0.52 (0.63%)

AZN

AstraZeneca

$39.98

0.3 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 20

    Jun

  • 20

    Jun

  • 24

    Jun

  • 16

    Jul

  • 30

    Jul

  • 06

    Aug

  • 16

    Sep

  • 20

    Sep

TTMI

TTM Technologies

$9.46

0.05 (0.53%)

06:32
06/18/19
06/18
06:32
06/18/19
06:32
Recommendations
TTM Technologies analyst commentary  »

TTM Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCE

BCE

$44.29

-0.345 (-0.77%)

06:27
06/18/19
06/18
06:27
06/18/19
06:27
Upgrade
BCE rating change  »

BCE upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

JPM

JPMorgan

$109.20

-0.64 (-0.58%)

, GS

Goldman Sachs

$190.74

-0.97 (-0.51%)

06:25
06/18/19
06/18
06:25
06/18/19
06:25
Periodicals
JPMorgan working on secretive digital banking project, TechCrunch reports »

JPMorgan (JPM) is working…

JPM

JPMorgan

$109.20

-0.64 (-0.58%)

GS

Goldman Sachs

$190.74

-0.97 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 09

    Jul

  • 16

    Jul

  • 16

    Jul

  • 06

    Aug

ARRY

Array BioPharma

$46.42

16.83 (56.88%)

06:22
06/18/19
06/18
06:22
06/18/19
06:22
Downgrade
Array BioPharma rating change  »

Array BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$225.00

10.19 (4.74%)

06:21
06/18/19
06/18
06:21
06/18/19
06:21
Periodicals
Musk deletes tweet attacking Tesla co-founder Eberhard, Business Insider reports »

Tesla CEO Elon Musk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$140.95

-0.69 (-0.49%)

06:19
06/18/19
06/18
06:19
06/18/19
06:19
Recommendations
Disney analyst commentary  »

Media survey shows strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

RTN

Raytheon

$179.77

2.39 (1.35%)

06:18
06/18/19
06/18
06:18
06/18/19
06:18
Hot Stocks
Raytheon, Black Sage partner on drone detection »

Raytheon and Black Sage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGI

Triumph Group

$18.69

-1.37 (-6.83%)

06:17
06/18/19
06/18
06:17
06/18/19
06:17
Hot Stocks
Triumph Group unit to provide engineering services for Mitsubishi Aircraft »

Triumph Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

AZN

AstraZeneca

$39.98

0.3 (0.76%)

, MRK

Merck

$83.30

0.52 (0.63%)

06:16
06/18/19
06/18
06:16
06/18/19
06:16
Hot Stocks
AstraZeneca's Lynparza approved as 1st line ovarian cancer maintenance treatment »

AstraZeneca (AZN) and…

AZN

AstraZeneca

$39.98

0.3 (0.76%)

MRK

Merck

$83.30

0.52 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 20

    Jun

  • 20

    Jun

  • 24

    Jun

  • 16

    Jul

  • 30

    Jul

  • 06

    Aug

  • 16

    Sep

  • 20

    Sep

TGI

Triumph Group

$18.69

-1.37 (-6.83%)

06:15
06/18/19
06/18
06:15
06/18/19
06:15
Hot Stocks
Triumph Group, Air France announce strategic alliance »

Triumph Group and Air…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

UTX

United Technologies

$124.14

-1.16 (-0.93%)

06:14
06/18/19
06/18
06:14
06/18/19
06:14
Hot Stocks
United Technologies' Collins Aerospace secures more than $1.5B in agreements »

Collins Aerospace…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$144.98

0.39 (0.27%)

, VOLVY

Volvo

$0.00

(0.00%)

06:12
06/18/19
06/18
06:12
06/18/19
06:12
Hot Stocks
Nvidia, Volvo partner to develop AI platform for autonomous trucks »

The Volvo Group (VOLVY)…

NVDA

Nvidia

$144.98

0.39 (0.27%)

VOLVY

Volvo

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 15

    Aug

AL

Air Lease

$38.66

-0.185 (-0.48%)

, EADSY

Airbus

$0.00

(0.00%)

06:12
06/18/19
06/18
06:12
06/18/19
06:12
Hot Stocks
Air Lease announces lease placement of 6 new Airbus A330-900neos with Virgin »

Air Lease (AL) announced…

AL

Air Lease

$38.66

-0.185 (-0.48%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

WHD

Cactus

$30.63

-0.505 (-1.62%)

06:10
06/18/19
06/18
06:10
06/18/19
06:10
Recommendations
Cactus analyst commentary  »

Cactus price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VWAGY

Volkswagen

$0.00

(0.00%)

06:10
06/18/19
06/18
06:10
06/18/19
06:10
Hot Stocks
Volkswagen aims to boost in-house software development to 60% by 2025 »

Volkswagen AG said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AL

Air Lease

$38.66

-0.185 (-0.48%)

, EADSY

Airbus

$0.00

(0.00%)

06:10
06/18/19
06/18
06:10
06/18/19
06:10
Hot Stocks
Air Lease announces lease placement of 3 new Airbus A321-200neo with Sky Airline »

Air Lease (AL) announced…

AL

Air Lease

$38.66

-0.185 (-0.48%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

SPR

Spirit AeroSystems

$79.73

1.16 (1.48%)

, EADSY

Airbus

$0.00

(0.00%)

06:09
06/18/19
06/18
06:09
06/18/19
06:09
Hot Stocks
Spirit AeroSystems announces role across four projects on Airbus program »

Spirit AeroSystems (SPR)…

SPR

Spirit AeroSystems

$79.73

1.16 (1.48%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.